BiondVax Pharmaceuticals (DE:2F5)
FRANKFURT:2F5

BiondVax Stock Price & Analysis

0 Followers

2F5 Stock Chart & Stats

Day’s Range€7.32 - €10.03
52-Week Range― - ―
Previous Close€8.55
Volume0.00
Average Volume (3M)N/A
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
EPS (TTM)N/A
Shares Outstanding1,885,576
R-SquaredN/A
Standard DeviationN/A
10 Day Avg. Volume0
30 Day Avg. Volume0
Price to Book (P/B)13.15
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-2.40
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target UpsideN/A
Rating ConsensusN/A
AlphaN/A
Number of Analyst Covering0


2F5 FAQ

What was BiondVax’s price range in the past 12 months?
Currently, no data Available
What is BiondVax’s market cap?
Currently, no data Available
When is BiondVax’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were BiondVax’s earnings last quarter?
Currently, no data Available
Is BiondVax overvalued?
According to Wall Street analysts BiondVax’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
    Does BiondVax pay dividends?
    BiondVax does not currently pay dividends.
    What is BiondVax’s EPS estimate?
    BiondVax’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does BiondVax have?
    Currently, no data Available
    What happened to BiondVax’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of BiondVax?
    Among the largest hedge funds holding BiondVax’s share is ARK Investment Management LLC. It holds BiondVax’s shares valued at N/A.

      ---

      BiondVax Stock Smart Score

      This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
      Learn more about TipRanks Smart Score

      Company Description

      BiondVax Pharmaceuticals

      BiondVax Pharmaceuticals Ltd. is a clinical stage biopharmaceutical company focused on developing and commercializing immunomodulation therapies for infectious diseases. It works on M-001, a synthetic peptide-based protein targeting both seasonal and pandemic strains of the influenza virus. The company was founded by Ron Babecoff and Rami Epstein on July 22, 2003 and is headquartered in Jerusalem, Israel.

      ---

      Forecast EPS vs Actual EPS

      Currently, no data available
      Please return soon. This page is being updated.

      Similar Stocks
      Company
      Price & Change
      Follow
      Mediwound
      BiondVax
      PolyPid
      PainReform
      RedHill Biopharma

      Popular Stocks

      ---
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis